Peripheral Vascular Devices Market to Reach US$ 18.9 Billion by 2033 at 7.2% CAGR Driven by Innovation from Medtronic, Boston Scientific, Abbott, Terumo, and Becton Dickinson

DataM Intelligence has released a new research report titled "Peripheral Vascular Devices Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Peripheral Vascular Devices Market.

Ready to scale in the Peripheral Vascular Devices Market? Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/peripheral-vascular-devices-market?prtk

The Global Peripheral Vascular Devices Market reached US$ 10.8 Billion in 2025 and is expected to reach US$ 18.9 Billion by 2033, growing at a CAGR of 7.2% during the forecast period 2026-2033.

The market is witnessing strong growth driven by the rising prevalence of peripheral artery disease (PAD), diabetes, and cardiovascular disorders worldwide. Increasing adoption of minimally invasive procedures, technological advancements in angioplasty balloons, stents, and atherectomy devices, and growing geriatric populations are accelerating demand. Additionally, the shift toward outpatient vascular interventions and improved reimbursement frameworks are further supporting market expansion, enabling faster recovery times and better clinical outcomes.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/peripheral-vascular-devices-market?prtk

Key Industry Developments

United States:

✅ March 2026: Medtronic launched an advanced drug-coated balloon platform designed for below-the-knee arterial disease, improving patency rates and reducing repeat interventions in PAD patients.

✅ January 2026: Boston Scientific introduced a next-generation peripheral stent system featuring enhanced flexibility and drug-eluting capabilities for complex vascular lesions.

✅ November 2025: Abbott expanded its vascular portfolio with a novel imaging-guided atherectomy device aimed at precision plaque removal and reduced procedural complications.

Japan:

✅ February 2026: Terumo Corporation unveiled a low-profile angioplasty balloon catheter optimized for small vessel interventions, supporting minimally invasive treatment approaches.

✅ December 2025: Nipro Corporation advanced vascular access technologies with a new line of peripheral guidewires designed for improved navigation in tortuous vessels.

✅ October 2025: Asahi Intecc strengthened its R&D in microcatheter technologies, enhancing device deliverability and procedural success rates in complex interventions.

Key Players:

Medtronic plc | Boston Scientific Corporation | Abbott Laboratories | Terumo Corporation | Becton, Dickinson and Company | Cardinal Health Inc. | Cook Medical | Biotronik SE & Co. KG | Asahi Intecc Co., Ltd. | Nipro Corporation

Strategic Leadership Analysis: Top 5 Key Players in Peripheral Vascular Devices Market 2026

-Medtronic plc: Continues to lead with its broad portfolio of drug-coated balloons, stents, and atherectomy devices, focusing on innovation in minimally invasive vascular therapies and expanding global clinical trials.

-Boston Scientific Corporation: Strengthens its leadership through advanced peripheral stent systems and drug-eluting technologies, targeting complex lesion treatment and improving long-term vessel patency.

-Abbott Laboratories: Drives innovation with imaging-guided vascular interventions and integrated diagnostic solutions, enhancing precision in peripheral procedures and patient outcomes.

-Terumo Corporation: Expands its global footprint with high-quality catheters and guidewires, emphasizing safety, flexibility, and minimally invasive device design.

-Becton, Dickinson and Company: Focuses on vascular access and interventional solutions, leveraging strong distribution networks and continuous product enhancements to capture market share.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/peripheral-vascular-devices-market?prtk

Main Drivers and Trends Shaping the Future of the Peripheral Vascular Devices Market

-Rising PAD and Diabetes Burden: Increasing incidence of peripheral artery disease and diabetes is significantly driving demand for vascular intervention devices globally.

-Shift Toward Minimally Invasive Procedures: Growing preference for catheter-based treatments over open surgeries is boosting adoption of angioplasty balloons, stents, and atherectomy systems.

-Technological Advancements: Innovations such as drug-coated balloons, bioresorbable stents, and imaging-guided interventions are improving procedural success and patient outcomes.

-Aging Population: Expanding geriatric population prone to vascular diseases is contributing to sustained market demand.

-Market Hurdles: High device costs, stringent regulatory approvals, and risks associated with device failure or restenosis remain key challenges.

Regional Insights:

-North America: 41.5% (Largest share, driven by advanced healthcare infrastructure, high PAD prevalence, and strong presence of leading market players).

-Europe: 27% (Supported by increasing adoption of minimally invasive vascular procedures and favorable reimbursement policies).

-Asia Pacific: 22.8% (Fastest growing, fueled by rising healthcare investments, large patient pool, and expanding access to vascular treatments in China, India, and Japan).

-Latin America: 5.2% (Emerging growth due to improving healthcare systems and increasing awareness of vascular diseases).

-Middle East & Africa: 3.5% (Gradual growth driven by expanding healthcare infrastructure and medical tourism).

Market Opportunities & Challenges: Peripheral Vascular Devices Market 2026

-Opportunities: Increasing adoption of drug-coated and bioresorbable devices is transforming vascular interventions, while expansion of outpatient and ambulatory surgical centers is creating new growth avenues. Emerging markets offer significant untapped potential due to rising disease burden and improving healthcare access. Integration of AI-based imaging and robotic-assisted interventions is expected to further enhance procedural precision.

-Challenges: High procedural costs and limited access in low-income regions restrict adoption. Product recalls and strict regulatory requirements can delay product launches. Additionally, clinical risks such as restenosis and thrombosis continue to pose challenges to long-term treatment success.

Market Segmentation Analysis:

-By Product Type: Angioplasty Balloons Dominate the Market
Angioplasty balloons hold the largest share due to their widespread use in opening narrowed or blocked arteries in minimally invasive procedures. Stents follow, driven by drug-eluting technologies that reduce restenosis rates. Catheters and guidewires play critical roles in navigation and access, while atherectomy devices are gaining traction for plaque removal in complex lesions. Others include inferior vena cava (IVC) filters and vascular grafts.

-By Application: Peripheral Artery Disease Leads Demand
Peripheral artery disease represents the dominant application segment, owing to its high global prevalence. Venous diseases and dialysis access applications are also significant, supported by increasing chronic kidney disease cases. Other applications include aneurysm repair and thrombus management.

-By End User: Hospitals Remain Primary Users
Hospitals account for the largest share due to the availability of advanced infrastructure and skilled professionals for vascular interventions. Ambulatory surgical centers are growing rapidly due to cost efficiency and shorter hospital stays. Specialty clinics and others also contribute to market expansion.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=peripheral-vascular-devices-market?prtk

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTW

Contact:

Fabian
DataM Intelligence 4Market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from research to consulting. The firm leverages key trends, insights, and developments to deliver swift and strategic solutions to clients. With a robust database of 6300+ reports across 40+ domains, DataM Intelligence supports over 200+ companies across 50+ countries, addressing critical business research needs that influence growth and innovation.

This release was published on openPR.